Fostering Coopetition Through Market Extension and Co-Creation in the Global Pharmaceutical Sector
39 Pages Posted: 9 Jun 2011 Last revised: 15 Dec 2015
Date Written: December 1, 2015
Abstract
We explore conditions under which collaboration between pharmaceutical firms from 'advanced' and emerging countries becomes preferable to rivalry. We show that that when agreements, such as Trade Related Aspects of Intellectual Property (IP) Rights, allow advanced country firms to take legal action against emerging country firms, whose products are perceived as infringing their IP, collaboration can prove preferable to both parties when the latter can leverage complementary assets and capabilities to extend and co-create market space. This co-opetitive outcome is fostered when the scope and duration of IP rights is contestable. Important implications follow for managerial practice.
Keywords: patents, TRIPS, MNPCs, bargaining
JEL Classification: L0, K0, O24, O32, O33, O34
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Intellectual Property Rights and North-South Trade
By Judith C. Chin and Gene M. Grossman
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Reaping What You Sow: An Empirical Analysis of International Patent Harmonization
-
International Protection of Intellectual Property
By Gene M. Grossman and Edwin L.-c. Lai
-
Patents, Appropriate Technology, and North-South Trade
By Ishac Diwan and Dani Rodrik
-
The North's Intellectual Property Rights Standard for the South?
By Edwin L.-c. Lai and Larry D. Qiu